nivolumab confers better os in patients with metastatic squamous cell carcinoma of the head and neck
Published 8 years ago • 1K plays • Length 7:13Download video MP4
Download video MP3
Similar videos
-
6:19
nivolumab-related efficacy and toxicity in hnscc patients
-
1:17
dr. ferris on fda approval of nivolumab in patients with head and neck cancer
-
28:48
the changing treatment landscape in recurrent/metastatic squamous cell carcinoma of head & neck
-
2:36
ca209-9ky: imrt nivolumab for recurrent head and neck squamous cell cancer
-
9:31
study in patients with recurrent ir metastatic head & neck squamous cell carcinoma
-
2:38
3 types of skin cancer
-
5:08:54
circulating tumor cells 2.0 - oncodiscover
-
29:28
head & neck cancer treatment decisions: what’s right for you?
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
6:51
pembrolizumab and nivolumab in recurrent hnscc
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
6:17
nivolumab in refractory metastatic squamous cell carcinoma...
-
2:13
nivolumab in hnscc
-
1:13
keynote-b84: pepinemab pembrolizumab for metastatic/recurrent head & neck squamous cell carcinoma
-
1:15
dr. ferris on significance of checkmate-141 trial for head and neck cancer
-
2:37
pembrolizumab is effective in recurrent, metastatic squamous cell carcinomas of the head and neck
-
1:36
dr. ferris on potential of nivolumab in head and neck cancer
-
0:55
dr. cohen on immunotherapy in head and neck squamous cell carcinoma
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
1:52
hcrn gu16-260: nivolumab and salvage nivolumab ipilimumab in treatment-naïve patients with adv...
-
6:16
treatment-free survival results of nivolumab and salvage nivolumab ipilimumab for accrcc
-
7:52
how patients with advanced/metastatic cscc present